Physician profile
Sonia E Palermo
NPI 1578700472
$2,072.22
in general payments reported to CMS, 2019-2025
14 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $303 · 2023: $517 · 2024: $710 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,519.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,170.08 | 2021-2025 | Octrode, Proclaim, Eterna |
| Biotronik Nro, INC. | $233.58 | 2024-2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $215.98 | 2024-2025 | Relistor |
| Vertos Medical, INC. | $115.05 | 2023-2024 | Mild Device Kit |
| Averitas Pharma INC. | $71.45 | 2023-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $62.27 | 2022-2023 | Belbuca |
| Nevro Corp. | $52.86 | 2023-2024 | Senza |
| Scilex Pharmaceuticals INC. | $39.51 | 2024 | |
| Tersera Therapeutics LLC | $31.51 | 2023 | Prialt |
| Boston Scientific Corporation | $21.66 | 2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $16.41 | 2023 | Intellis Adaptivestim |
| Foundation Fusion Solutions, LLC | $15.62 | 2025 | |
| Abbvie INC. | $13.16 | 2023 | |
| Biodelivery Sciences International, INC. | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Palermo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.